We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

86 hedge funds and large institutions have $135M invested in abrdn Life Sciences Investors in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 3

135% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 17

18% more funds holding

Funds holding: 73 → 86 (+13)

1.71% less ownership

Funds ownership: 30.44% → 28.73% (-1.7%)

8% less capital invested

Capital invested by funds: $147M → $135M (-$12.3M)

Holders
86
Holders Change
+13
Holders Change %
+17.81%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
40
Reduced
17
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$6.79M
2
Allspring Global Investments
Allspring Global Investments
North Carolina
+$2.21M
3
Raymond James Financial
Raymond James Financial
Florida
+$1.07M
4
AIA
Absolute Investment Advisers
Florida
+$598K
5
FAM
Formidable Asset Management
Ohio
+$567K

Top Sellers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
-$19.6M
2
LCM
Landscape Capital Management
New Jersey
-$1.16M
3
PCM
Penserra Capital Management
California
-$1.14M
4
WAM
Wolverine Asset Management
Illinois
-$999K
5
SFS
Shaker Financial Services
Virginia
-$689K
Name Holding Trade Value Shares
Change 		Change in
Stake
AssetMark Inc
76
AssetMark Inc
California
$4.31K – – –
HWP
77
Highline Wealth Partners
California
$2.85K +$418 +25 +17%
RFP
78
Root Financial Partners
California
$2.28K +$2.34K +140 New
ACA
79
Atlas Capital Advisors
Wyoming
$2.25K – – –
SIC
80
Salem Investment Counselors
North Carolina
$2.03K +$2.09K +125 New
WTC
81
WhitTier Trust Company
Nevada
$629 +$618 +37 New
Rockefeller Capital Management
82
Rockefeller Capital Management
New York
$602 +$618 +37 New
NIM
83
Nexus Investment Management
Ontario, Canada
$521 +$535 +32 New
UBS AM
84
UBS AM
Illinois
$212 +$217 +13 New
HNB
85
Huntington National Bank
Ohio
$122 – – –
JWA
86
JFS Wealth Advisors
Pennsylvania
$49 – – –
JP Morgan Chase
87
JP Morgan Chase
New York
$32 +$33 +2 New
LCM
88
Landscape Capital Management
New Jersey
– -$1.16M -69,030 Closed
SIS
89
Sound Income Strategies
Florida
– -$1.08K -65 Closed
PNC Financial Services Group
90
PNC Financial Services Group
Pennsylvania
– -$705 -42 Closed
1 2 3
4

HQL Hedge Fund Activity: Q1 2026 in Review

86 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2026, worth a combined $135M — down 8.3% from $147M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HQL positions and 3 closed out — a net gain of 15 holders — while 40 added to existing stakes and 17 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $6.79M. The largest seller was Saba Capital Management, cutting an estimated $19.6M.

  • 86 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2026, up from 73 in Q4 2025.
  • Funds reported $135M of abrdn Life Sciences Investors stock for Q1 2026, down 8.3% quarter-over-quarter.
  • 18 funds opened new abrdn Life Sciences Investors positions in Q1 2026 and 3 closed out, a net change of +15 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2026 was Morgan Stanley, an estimated $6.79M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2026 was Saba Capital Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2026.